Interestingly, a few other cancer types, such as some human breast cancers, adrenocortical carcinoma and kidney chromophobe cell carcinoma, also exhibit an increased SHMT2 expression in metastatic tumor tissue during cancer progression [53]. The gene discussed is SHMT2; the disease is cancer.